OverviewChartNewsTraderScreen

HSBC Aktienanleihe BAYN 24.05.202.../  DE000HS1S1D2  /

Frankfurt Zert./HSBC
5/10/2024  7:56:09 PM Chg.+0.710 Bid8:32:41 PM Ask8:32:41 PM Underlying Strike price Expiration date Option type
60.730EUR +1.18% 60.720
Bid Size: 20,000		 60.920
Ask Size: 20,000		 BAYER AG NA O.N. 48.00 EUR 5/24/2024 Call
GlobeNewswire 5/2 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...
GlobeNewswire 4/18 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...
GlobeNewswire 4/16 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...
GlobeNewswire 4/11 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...
GlobeNewswire 4/9 AskBio Names Mansuo Shannon Chief Scientific Officer
GlobeNewswire 3/25 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...
GlobeNewswire 3/14 Bayer and Aignostics to collaborate on next generation precision oncology
GlobeNewswire 3/6 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...
TeleTrader 3/5 Bayer's Q4 sales at €11.9 billion
GlobeNewswire 3/4 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
TeleTrader 3/4 Earnings preview: Bayer, Broadcom among those in calendar
GlobeNewswire 2/15 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust
GlobeNewswire 2/13 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...
GlobeNewswire 2/13 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure
TeleTrader 1/29 Bayer down over 5% after latest $2.25B Roundup ruling
TeleTrader 1/17 Bayer to cut jobs amid 'difficult situation'
GlobeNewswire 1/5 AskBio Announces Initiation of Phase 2 GenePHIT Trial in Congestive Heart Failure (CHF)
GlobeNewswire 1/4 AskBio Phase Ib trial of AB-1005 gene therapy in patients with Parkinson’s disease meets primary end...
GlobeNewswire 12/14/2023 Iktos and Bayer Announce Collaboration to expand the use of Artificial Intelligence to Design New Su...
GlobeNewswire 12/6/2023 NFWF Announces $4.1 Million in Grants to Conserve the Monarch Butterfly and Other Insect Pollinators
TeleTrader 11/20/2023 Bayer's stock slumps over 16% on study halt, Roundup ruling
GlobeNewswire 11/9/2023 Bayer and Recursion Focus Research Collaboration on Oncology
GlobeNewswire 11/9/2023 Recursion Announces Data Collaboration Deal with Tempus, Top 50 Supercomputer Ambition Powered by NV...
TeleTrader 11/8/2023 Bayer reports sales of €10.3 billion in Q3
TeleTrader 8/8/2023 Bayer sales fall 14% to €11 billion in Q2